Clinical Trial Update: Synergism of Immunomodulation and Tumor Ablation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating immunomodulation combined with tumor ablation in colorectal cancer with liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: COMPLETED